Moxetumomab pasudotox-tdfk Intravenous and Mycophenolic acid
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Mycophenolic acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: mycophenolic acid
Brand name: Myfortic
Synonyms: Mycophenolate Tablets Delayed Release
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Mycophenolic Acid Delayed-Release Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Mycophenolic Acid Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Mycostatin (Nystatin Oral Suspension)
- Moxetumomab pasudotox-tdfk Intravenous-Mycostatin (Nystatin Tablets and Capsules)
- Moxetumomab pasudotox-tdfk Intravenous-Mycostatin Suspension
- Moxetumomab pasudotox-tdfk Intravenous-Mydayis
- Mycophenolic acid-Moxifloxacin
- Mycophenolic acid-Moxifloxacin (Systemic)
- Mycophenolic acid-Moxifloxacin Hydrochloride
- Mycophenolic acid-Moxifloxacin Injection
- Mycophenolic acid-Moxifloxacin Intravenous
- Mycophenolic acid-Moxifloxacin Tablets